Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mihaela Calcaianu
Withdrawal of Long-Term Epoprostenol Therapy in Pulmonary Arterial Hypertension (PAH)
Pulmonary Circulation
Pulmonary
Respiratory Medicine
Related publications
High Plasma Serotonin Levels in Primary Pulmonary Hypertension : Effect of Long-Term Epoprostenol (Prostacyclin) Therapy
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Children With Pulmonary Arterial Hypertension and Prostanoid Therapy: Long-Term Hemodynamics
Journal of Heart and Lung Transplantation
Cardiology
Transplantation
Cardiovascular Medicine
Pulmonary
Respiratory Medicine
Surgery
Epoprostenol Treatment for Idiopathic Pulmonary Arterial Hypertension in Pregnancy
Journal of Perinatology
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Short-Term and Long-Term Epoprostenol (Prostacyclin) Therapy in Pulmonary Hypertension Secondary to Connective Tissue Diseases: Results of a Pilot Study
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
242 Long-Term Prognosis of Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension: Cstar-Pah Cohort Study
Successful Titration of Triple Oral Therapy in a Patient With Pulmonary Arterial Hypertension (PAH)
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
P2 In-Flight Hypoxaemia in Patients With Pulmonary Arterial Hypertension (PAH)
Thorax
Pulmonary
Respiratory Medicine
Development of a New Patient-Reported Outcome (PRO) Instrument for Pulmonary Arterial Hypertension (PAH): The Pulmonary Arterial Hypertension–symptoms and Impact (PAH-SYMPACT) Questionnaire
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Continuous Intravenous Epoprostenol for Pulmonary Arterial Hypertension: Highlighting Practical Issues, Special Considerations
Advances in Pulmonary Hypertension
